Investors
News
Contact
About us
Board of Directors
Management
Our Team
Sustainability
Career
Investors
Products
Products
ICOres
ICOcap
ICOpre
ICOone
ICOone Nasal
Patents
Capabilities
Capabilities
Devices
Formulation
Characterization
General Support
Collaborations
Iconovo Accelerator Program
Insights
Replacing injections with inhalation
Boost your business with an innovative inhaler partner
Investors
Search
Menu
Menu
LinkedIn
Twitter
Dr Orest Lastow, CTO and founder
Roger Lassing,
VP Business Development
Strategi, affärsmodell och möjligheter för Iconovo – Johan Wäborg, VD
Iconovos anpassningsbara plattformar för inhalationsprodukter – Orest Lastow, Chief Technology Officer
Ökade insatser på en attraktiv marknad – Roger Lassing, VP Business Development
Sammanfattning och frågestund – Johan Wäborg, VD
3.
INHALATION GENERICS
Generics business – Dr Orest Lastow, Roger Lassing
Scroll to top